Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Thuja orientalis is an evergreen coniferous tree in the cypress family (Cupressaceae), used in traditional East Asian medicine. Extracts from the leaves, twigs, and seeds are used for a variety of indications, such as treating gout, rheumatism, diarrhea, chronic tracheitis, and hair loss. In preclinical studies, its extracts have demonstrated anti-inflammatory, immunomodulatory, and possible hair-growth-promoting effects. Mechanistically, Thuja orientalis may exert its effects by reducing Th2 cytokines (IL-4, IL-5, and IL-13) and eotaxin, inhibiting expression of inducible nitric oxide synthase (iNOS) and matrix metalloproteinase-9 (MMP-9) in inflammatory models, and acting as a 5α-reductase inhibitor, which might be relevant in androgenetic alopecia. The plant contains bioactive compounds including flavonoids and diterpenes. No large, high-quality clinical trials for single-ingredient Thuja orientalis products have been published.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on thuja orientalis.